European Graves’ Disease Market: Global Size, Share, Industry Trends, Research and Forecast 2019-2025

1. Orion Market Research European Graves’ disease Market: Size, Share, Growth, Industry Analysis, Opportunities and Forecast 2019-2025 Request https://www.omrglobal.com/request-sample/european-graves-disease-market a free sample of our report on European Graves’ disease Market: ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

2. European Graves’ disease market is growing at a CAGR of around 4.4% during the forecast period. Europe consists of numerous key economies including the UK, Germany, Spain, Italy, and Russia among various others which play a significant role in the development of the Grave’s market in the region. The key reason which is promoting the growth of the market in Europe is the changing lifestyle and higher prevalence of smoking in the countries of European region is expected to promote the prevalence of Grave’s disease, thereby creating opportunity for the growth of the European Graves’ diseases market over the forecast period. A full report of European Graves’ Disease Market is available at: https://www.omrglobal.com/industry- reports/european-graves-disease-market Europe is the well-established region comprises of few of the largest economies of the world. The region has established healthcare industry due to growing funding in the healthcare R&D and awareness programs. This directly impacts the funding and awareness about thyroid related diseases such as Grave’s disease, thyroid cancer and others. Presence of the key market players such as Apitope technology Ltd., GlaxoSmithKline PLC and others is also affecting the growth of the market. Growing prevalence of type-1 diabetes is one of the major factors contributing significantly in the European Grave’s disease market. To know more information, please request a free report sample https://www.omrglobal.com/request- sample/european-graves-disease-market Further, Apitope International NV is a biotechnology company, based in Belgium, that manufactures and markets commercialized products for autoimmune disease. The company provides product candidate ATX-GD-59 that is a disease-modifying treatment for Grave’s disease. ATX-GD-59 is presently being assessed in a Phase I study in patients and the company plans to initiate a Phase II study in the first quarter of 2019. Thus, the presence of the market players strengthens the domestic presence and also aids in the growth of the European Graves’ disease market. European Graves’ Disease Market – Segmentation by Diagnosis Ultrasound Imaging Tests Radioactive Iodine Uptake Blood Sample

3. by Treatment Anti- Thyroid Medication Radioactive Iodine Therapy Surgery For more customized data, request for report customization @ https://www.omrglobal.com/report- customization/european-graves-disease-market European Graves’ Disease Market – Segment by Region UK Germany France Italy Spain Rest of Europe Company Profiles Abbott Laboratories Inc. Allergan PLC Eli Lilly and Co. GlaxoSmithKline PLC Johnson & Johnson Macleods Pharmaceuticals Ltd. Merck & Co. Inc. Mylan NV Novartis International AG Pfizer Inc. Sanofi SA Takeda Pharmaceutical Co. Ltd. About Orion Market Research OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

4. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404